Related Experiment Video
Updated: Jun 1, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response
1JAMBUR ANANTH, M.D., Harbor-UCLA Medical Center, 1000 W, Carson Street, Building 1-South Torrance, CA 90509, USA.
Abstract:
This study was designed to assess the relationship between psychopathology and serotonin generated prolactin response to clomipramine and to assess the relationship between improvement in psychopathology and prolactin levels. The experimental sample consisted of 15 patients in the drug and 12 patients in the placebo groups. Blood samples for prolactin levels were drawn at baseline, and at the end of 4,8, and 12 weeks. There were statistically significant differences in prolactin increase between the drug and the placebo groups at 4 but not at 12 weeks following treatment. When the four least improved and a similar number of the most improved patients were compared, the least improved patients had the most increase in prolactin and the most improved had the least increase.
Related Concept Videos
Obsessive-Compulsive Disorder
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview

